Engagement Supports Commercial Readiness Strategy for MaxYield™ and CardioYield™ in the United States TORONTO, ON / ACCESS Newswire / February 10, 2026 / AI/ML Innovations Inc. ("AIML" ...

Engagement Supports Commercial Readiness Strategy for MaxYield and CardioYield in the United States TORONTO, ON / ACCESS Newswire / February 10, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") ...

Hypermobile Ehlers-Danlos syndrome (hEDS) is one of the most common heritable connective tissue disorders. Early estimates have reported that this genetic disorder affects at least one in 5,000 ...

Davos panel weighs AI’s healthcare promise against regulation, bias, and need for causal, brain-inspired models.

Restore Brain executive John Cavanagh shared neuroscience-based insights on TMS during a recent behavioral health summit held ...

Scientists stress that the study represents an early signal, not a medical breakthrough. It identifies a potential avenue for ...

Our current approach to mental health labelling and diagnosis has brought benefits. But as a practising doctor, I am concerned that it may be doing more harm than good ...

TCTMD spoke with Lior Jankelson, MD, PhD (NYU Langone Health, New York, NY), an electrophysiologist who leads the AI/machine ...

Post-traumatic stress disorder is often described as a brain stuck in survival mode, with threat circuits firing long after the danger has passed. Now researchers are zeroing in on a specific neural ...

Detailed price information for Vivos Therapeutics Inc (VVOS-Q) from The Globe and Mail including charting and trades.

Dementia has long been framed as an inevitable byproduct of aging, something to be managed rather than meaningfully delayed. A sprawling clinical trial of older adults now challenges that assumption, ...

Every day, more than 40 million people ask ChatGPT health-related questions, according to its creator OpenAI. But it's not ...